New York State Common Retirement Fund’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

New York State Common Retirement Fund’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-270	Closed	-$4K	–	3583
2022 Q1	$4K	Sell	270 -4	-1%	-$102	﹤0.01%	3336
2021 Q4	$13K	Sell	274 -2	-0.7%	-$210	﹤0.01%	3311
2021 Q3	$40K	Sell	276 -460	-63%	-$59.7K	﹤0.01%	3264
2021 Q2	$85K	Buy	736 +6	+0.8%	+$669	﹤0.01%	3228
2021 Q1	$70K	Buy	+730	New	+$95.2K	﹤0.01%	3153

Other funds holding LABP

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's LABP Position: Q2 2022 in Review

New York State Common Retirement Fund sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2022, closing a stake of 270 shares — an estimated $4K sold.

New York State Common Retirement Fund first reported a position in LABP in Q1 2021 and held it in 5 quarters. The position peaked at $85K in Q2 2021. 34 funds tracked by Wall St. Rank hold LABP as of Q2 2022.

New York State Common Retirement Fund reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 270 Landos Biopharma, Inc. Common Stock shares in Q2 2022, an estimated $4K.
New York State Common Retirement Fund first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
New York State Common Retirement Fund's Landos Biopharma, Inc. Common Stock position peaked at $85K in Q2 2021.
34 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2022.

Based on New York State Common Retirement Fund's 13F filing for Q2 2022, filed 4 Aug 2022.